Open AccessComparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis
Author(s) -
Prathyusha Rampally,
Rekha Rani Koduganti,
Sastri Nadiminty Ganapathi,
Veerendranath Reddy Panthula,
Prasanna Jammula Surya
Publication year - 2019
Publication title -
journal of indian society of periodontology (print)/journal of indian society of periodontology (online)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.309
H-Index - 28
eISSN - 0975-1580
pISSN - 0972-124X
DOI - 10.4103/jisp.jisp_528_18
Subject(s) - medicine , diabetes mellitus , aspirin , periodontitis , chronic periodontitis , type 2 diabetes , periodontology , type 2 diabetes mellitus , gastroenterology , gingivitis , dentistry , endocrinology
Periodontitis and diabetes are universally prevalent diseases which are interlinked with each other. Inflammatory products released both by the microorganisms, and the host plays a pivotal role in causing both the diseases. Pentraxins are acute-phase proteins which are often found to be elevated in inflammatory states. Anti-inflammatory agents have a very important role to play in curbing infection of which, aspirin and omega-3 fatty acids (O3FAs) are being administered often nowadays. Nonsurgical periodontal therapy (NSPT) remains the gold standard of treatment, and other agents have been used as adjuvants only, to increase the efficacy of treatment.